164 related articles for article (PubMed ID: 19118376)
21. Recurrent squamous cell carcinoma and follicular lymphoma arising in the scalp after treatment for lymphoma.
Wada DA; Agarwal N; Florell SR; Lim MS
Pathology; 2008 Apr; 40(3):316-20. PubMed ID: 18428060
[No Abstract] [Full Text] [Related]
22. Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.
Aoi J; Makino K; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Koga H; Hashimoto T; Ihn H
J Dermatol; 2013 Apr; 40(4):285-6. PubMed ID: 23398274
[No Abstract] [Full Text] [Related]
23. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
Boughan KM; Caimi PF
Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
[TBL] [Abstract][Full Text] [Related]
24. Maintenance rituximab should be considered for patients with follicular lymphoma.
Barr PM
Clin Adv Hematol Oncol; 2014 Aug; 12(8):541-3. PubMed ID: 25356579
[No Abstract] [Full Text] [Related]
25. Follicular lymphoma presenting follicular papules in the skin: A case report.
Ozaki S; Funasaka Y; Shimizu A; Kawarasaki M; Kanzaki A; Matano Y; Futagami A; Yamaguchi H; Sugisaki Y; Saeki H
J Dermatol; 2017 Jan; 44(1):111-113. PubMed ID: 27153936
[No Abstract] [Full Text] [Related]
26. Idiotype vaccination in follicular lymphoma: knocking on the doorway to cure.
Longo DL
J Natl Cancer Inst; 2006 Sep; 98(18):1263-5. PubMed ID: 16985240
[No Abstract] [Full Text] [Related]
27. Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.
Budau L; Wilhelm C; Moll R; Jäkel J; Hirt C; Dölken G; Maschmeyer G; Neubauer E; Strauch K; Burchert A; Herold M; Neubauer A
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2149-2156. PubMed ID: 31273513
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.
Alvaro T; Lejeune M; Salvadó MT; Lopez C; Jaén J; Bosch R; Pons LE
J Clin Oncol; 2006 Dec; 24(34):5350-7. PubMed ID: 17135637
[TBL] [Abstract][Full Text] [Related]
29. New anti-CD20 monoclonal antibodies: which is the best?
Gagez AL; Cartron G
Leuk Lymphoma; 2015 Jan; 56(1):1-2. PubMed ID: 24898669
[No Abstract] [Full Text] [Related]
30. Bilateral conjunctival follicular lymphoma in a child.
Wall PB; Traboulsi EI; Hsi ED; Singh AD
J AAPOS; 2015 Apr; 19(2):183-5. PubMed ID: 25824110
[TBL] [Abstract][Full Text] [Related]
31. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Provencio M; Cruz Mora MÁ; Gómez-Codina J; Quero Blanco C; Llanos M; García-Arroyo FR; de la Cruz L; Gumá Padró J; Delgado Pérez JR; Sánchez A; Alvarez Cabellos R; Rueda A;
Leuk Lymphoma; 2014 Jan; 55(1):51-5. PubMed ID: 23573825
[TBL] [Abstract][Full Text] [Related]
32. A treated case of follicular lymphoma presenting with fever and diarrhea.
Vaiphei K; Malhotra P; Sharma N; Narasiyappah AK; Varma SC
Indian J Gastroenterol; 2007; 26(5):240-3. PubMed ID: 18227577
[No Abstract] [Full Text] [Related]
33. NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients.
Doss S; Garrett Z; Sutcliffe F; Stevens A
Lancet Oncol; 2012 Feb; 13(2):128-30. PubMed ID: 22403811
[No Abstract] [Full Text] [Related]
34. Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.
Fend F; Quintanilla-Martínez L
Haematologica; 2014 Apr; 99(4):599-602. PubMed ID: 24688106
[No Abstract] [Full Text] [Related]
35. Current approaches and future perspectives for advanced-stage follicular lymphoma with a low tumor burden.
Fukuhara N; Ishizawa K
Jpn J Clin Oncol; 2019 Apr; 49(4):306-310. PubMed ID: 30715424
[TBL] [Abstract][Full Text] [Related]
36. Clinical features, prognosis and treatment of follicular lymphoma.
Salles GA
Hematology Am Soc Hematol Educ Program; 2007; ():216-25. PubMed ID: 18024633
[TBL] [Abstract][Full Text] [Related]
37. High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma.
Akamatsu N; Yamada Y; Hasegawa H; Makabe K; Asano R; Kumagai I; Murata K; Imaizumi Y; Tsukasaki K; Tsuruda K; Sugahara K; Atogami S; Yanagihara K; Kamihira S
Cancer Lett; 2007 Oct; 256(2):196-206. PubMed ID: 17624663
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma.
Yang SH; Kuo SH
Ann Hematol; 2008 Apr; 87(4):325-7. PubMed ID: 17932671
[No Abstract] [Full Text] [Related]
39. Primary Duodenal Follicular Lymphoma Treated With Rituximab Monotherapy and Followed-up for 15 Years.
Seki A; Iwamuro M; Yoshioka M; Fujii N; Okada H; Nose S; Takata K; Yoshino T; Yamamoto K
Acta Med Okayama; 2015; 69(5):301-6. PubMed ID: 26490027
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression.
Saito B; Shiozawa E; Yamochi-Onizuka T; Adachi D; Nakamaki T; Tomoyasu S; Omine M; Mitsuya T; Takimoto M; Ota H
Pathol Int; 2004 Sep; 54(9):667-74. PubMed ID: 15363034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
